Ultime notizie per GoodRx Holdings (NASDAQ:GDRX) Azioni

GoodRx Holdings

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings Inc

HC Wainwright &amp; Co. analyst Brandon Folkes assumes PolyPid (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPD#NASDAQ">PYPD</a>) with a Buy rating and announces Price Target of $11.

News

Price Target

Initiation

Analyst Ratings

PYPD

HC Wainwright & Co. Assumes PolyPid at Buy, Announces Price Target of $11

Goldman Sachs analyst Jordan Alliger upgrades Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) from Neutral to Buy and raises the price target from $45 to $65.

Upgrades

Goldman Sachs Upgrades Knight-Swift to Buy, Raises Price Target to $65

Goldman Sachs analyst Jordan Alliger upgrades Schneider National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNDR#NYSE">SNDR</a>) from Neutral to Buy and raises the price target from $24 to $32.

SNDR

Goldman Sachs Upgrades Schneider National to Buy, Raises Price Target to $32

KVUE

Kenvue Earns Spot On Fortune 500, Citing Strong Global Sales And Iconic Brand Portfolio

On Friday, May 30, U.S. markets closed mixed. The S&amp;P 500 ended flat but logged its strongest monthly gain since late last year, fueled by easing trade tensions, upbeat earnings, and subdued inflation. The Nasdaq also posted a solid monthly rise. Markets fluctuated on Trump&#8217;s conflicting trade signals, while investors held firm on rate cut expectations this fall.
In economic data, Consumer sentiment was revised to 52.2 in May from 50.8, while the Chicago PMI dropped to 40.5 from 44.6, indicating softer manufacturing.
Most S&amp;P 500 sectors ended lower Friday, led by losses in energy, consumer discretionary, and tech. Consumer staples and utilities outperformed, closing higher.
The Dow closed higher by 0.13% at 42,270.07, the S&amp;P 500 declined 0.01% to 5,911.69, and the Nasdaq fell 0.32% to 19,113.77.
Asia Markets Today
<ul class="wp-block-list">
<li>On Monday, Japan&#8217;s Nikkei 225 closed 1.32% lower at 37,463.50, led by losses in the Paper &amp; Pulp, Transport and Communication sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 fell 0.24%, ending the session at 8,414.10, led by losses in the Energy, Resources, Metals &amp; Mining sectors.</li>
<li>India&#8217;s Nifty 50 was down 0.13% at 23,157.97, and Nifty 500 rose 0.14% to 22,833.45.</li>
<li>China&#8217;s market was closed for the Dragon Boat Festival holiday.</li>
<li>Hong Kong&#8217;s Hang Seng closed the session 0.57% lower at 23,157.97.</li>
</ul>
Eurozone at 05:45 AM ET
<ul class="wp-block-list">
<li>The European STOXX 50 index was down 0.80%.</li>
<li>Germany&#8217;s DAX index declined 0.72%.</li>
<li>France&#8217;s CAC 40 fell 0.69%.</li>
<li>U.K.&#8217;s FTSE 100 index traded lower by 0.11%.</li>
</ul>
Commodities at 05:45 AM ET
<ul class="wp-block-list">
<li>Crude Oil WTI was trading higher by 3.57% at $62.97/bbl, and Brent was up 3.35% at $64.88/bbl.</li>
<li>Oil prices rose as OPEC+ kept July output hikes steady at 411,000 bpd. Tight supply, strong demand, and U.S. fuel concerns also supported the rally.</li>
<li>Natural gas rose 4.53% to $3.603.</li>
<li>Gold traded higher by 1.67% to $3,371.21, Silver rose 1.22% to $33.428, and Copper was up 4.66% to $4.8955.</li>
<li>Gold prices rose in Asian trade Monday amid renewed U.S.-China trade tensions and haven demand.</li>
</ul>
U.S. Futures at 05:45 AM ET
Dow Jones futures slid 0.50%, the S&amp;P 500 declined 0.57%, and the Nasdaq 100 was down 0.73%.
Forex at 05:45 AM ET
<ul class="wp-block-list">
<li>The U.S. Dollar Index declined 0.59% to 98.74, USD/JPY was down 0.81% to 142.89, and USD/AUD fell 0.79% to 1.5427.</li>
<li>The U.S. dollar fell Monday amid Trump&#8217;s tariff threats, China&#8217;s pushback, recession fears, and rising fiscal concerns. Rate-cut bets and safe-haven doubts added further pressure.</li>
</ul>
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Slide, Oil Gains 3% - Global Markets Today While US Slept

Needham analyst Serge Belanger maintains Liquidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) with a Buy and raises the price target from $25 to $32.

LQDA

Needham Maintains Buy on Liquidia, Raises Price Target to $32

Goldman Sachs analyst Jordan Alliger upgrades Werner Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WERN#NASDAQ">WERN</a>) from Sell to Buy and raises the price target from $25 to $39.

WERN

Goldman Sachs Upgrades Werner Enterprises to Buy, Raises Price Target to $39

CANG

Cango Enters Definitive Agreement With Founders And EWCL For $70M Class B Share Sale

BranchOut Food Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOF#NASDAQ">BOF</a>), a leading food technology company specializing in its patented GentleDry&#x2122; dehydrated snacks and ingredients, announces the execution of a strategic agreement with Kaufman Kapital LLC, resulting in a $1 million cash infusion through the early exercise of existing warrants. The agreement also includes amendments to existing financing terms that strengthen BranchOut's balance sheet, allow for debt repayment and extend key debt maturities.
Under the terms of the agreement, Kaufman Kapital will exercise in full an existing warrant to purchase 1,000,000 shares of BranchOut's common stock, providing the Company with $1,000,000 in cash proceeds no later than June 16, 2025.
In addition, the parties agreed to the following amendments:
<ul>
<li>Extension of the maturity date of the $3.4 million Senior Secured Convertible Promissory Note from December 31, 2025 to December 31, 2026.</li>
<li>Extension of the maturity date on the remaining $875,000 balance of the original $1.2 million Kaufman Senior Secured Promissory Note to December 31, 2025.</li>
<li>Extension of the expiration date of a separate warrant to purchase 500,000 shares to December 31, 2026 &nbsp;</li>
</ul>
"This Agreement reflects the strong confidence Kaufman Kapital has in our long-term growth strategy and operational execution," said Eric Healy, CEO of BranchOut Food. "The warrant exercise provides us with additional capital, while the note extensions improve our financial flexibility and strengthen our balance sheet."
Kaufman Kapital's decision to exercise its warrant ahead of schedule and extend key financing terms reflects continued confidence in BranchOut's trajectory. "We've been closely following BranchOut's progress, and the execution we're seeing across both operations and commercial growth is outstanding," said a spokesperson for Kaufman Kapital. "Our early exercise of the warrant reflects our strong confidence in the team, the business model, and the long-term opportunity. We're bullish on where BranchOut is headed and proud to support their continued momentum."
The $1 million in proceeds from the warrant exercise will be used to pay down outstanding debt obligations as part of BranchOut's broader initiative to eliminate all current liability notes payable by the end of 2025. This strategic use of capital reflects the Company's commitment to strengthening its balance sheet and positioning itself for sustained growth.

BranchOut Food Gets $1M Boost From Kaufman Kapital to Pay Down Debt and Fuel Growth

The new facility expands the Company's three loan agreements to a maximum borrowing capacity from $14.2 million to $23.0 million and extends the maturity date under each respective loan agreement from October 1, 2025 to April 30, 2027.
The additional borrowing capacity provides Solésence with significant financial flexibility to support its strategic objectives, including procurement of key raw materials and supplies at favorable pricing, improvement of lead times associated with packaging and product launches, and empowerment of the company's brand partners to drive product adoption.

Health Care

General

SLSN

Solésence Entered Into Amendments To Its Existing Loan Agreements, Providing Increased Borrowing Capacity To Support The Execution Of Strategic Objectives

Goldman Sachs analyst Jordan Alliger downgrades JB Hunt Transport Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) from Buy to Neutral and maintains the price target from $164 to $164.

Downgrades

JBHT

Goldman Sachs Downgrades JB Hunt Transport Servs to Neutral, Maintains Price Target to $164

<ul>
<li>Strategic combination establishes a market-leading mental health company with a pipeline that includes potentially transformative, rapid-acting psychedelic assets differentiated by their convenient route of administration and short time-in-clinic</li>
<li>Combined company will operate under the name atai Beckley with a joint leadership team and Board that leverage the deep psychedelic, drug development and CNS expertise within both organizations</li>
<li>Topline data from the Phase 2b study of BPL-003 in patients with treatment-resistant depression (TRD) is expected in mid-2025 - the largest controlled trial of mebufotenin (5-MeO-DMT) and the first and only controlled trial to investigate mebufotenin in the U.S.</li>
<li>The all-share transaction is expected to close in the second half of 2025</li>
<li>Concurrent $30.0M private placement by Ferring Ventures S.A. and Adage Capital Partners LP</li>
</ul>

ATAI

atai And Beckley Merger Advances Strategic Vision For Psychedelic Drug Development With Deep CNS Expertise

Goldman Sachs analyst Matt Reustle downgrades Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>) from Buy to Neutral and maintains the price target from $91 to $91.

Goldman Sachs Downgrades Canadian Pacific Kansas to Neutral, Maintains Price Target to $91

House Speaker Mike Johnson (R-La.) doubled down on his defense of President Donald Trump's "big, beautiful bill", arguing that those who <a href="https://www.benzinga.com/25/05/45278823/over-5-million-americans-set-to-lose-health-coverage-by-2034-amid-proposed-gop-medicaid-cuts-cbo-analysis">lose Medicaid</a> will do so by personal choice
What Happened: During an appearance <a href="https://www.nbcnews.com/meet-the-press/video/speaker-mike-johnson-denies-trump-bill-threatens-medicaid-coverage-full-interview-240675397944">on</a> NBC's Meet the Press, Johnson was asked about projections that 4.8 million people could lose Medicaid coverage under the new spending bill.
"Those 4.8 million people will not lose their Medicaid unless they choose to do so," he said. According to the plan, childless, able-bodied adults aged 19 to 64 are required to work or volunteer at least 20 hours a week to <a href="https://www.benzinga.com/25/05/45558613/house-advances-trumps-sweeping-one-big-beautiful-bill-after-key-medicaid-tax-and-border-security-changes">maintain eligibility for Medicaid.</a>
"You're telling me that you're going to require the able-bodied — these young men, for example, OK — to only work or volunteer in their community for 20 hours a week, and that's too cumbersome for them? I'm not buying it. The American people are not buying it," Johnson said.
See Also: <a href="https://www.benzinga.com/cannabis/25/06/45714305/elon-musk-says-doge-became-a-whipping-boy-for-everything-real-or-imagined-tesla-ceo-doesnt-agree-with-everything-white-house-does-but-wont-speak-out">Elon Musk Says DOGE Became A &#8216;Whipping Boy&#8217; For Everything Real Or Imagined — Tesla CEO Doesn&#8217;t Agree With Everything White House Does But Won&#8217;t Speak Out: &#8216;Creates A Bone Of Contention&#8217;</a>
On claims that <a href="https://www.benzinga.com/general/health-care/25/05/45344596/house-republicans-push-880-billion-medicaid-cuts-to-renew-trump-tax-breaks-democrat-warns-millions-will-lose-their-health-care">people could lose coverage</a> due to administrative obstacles, he said, "The people who are complaining about losing their coverage are doing so because they can't fulfill the paperwork." He said the policy was based on "common sense."
"When people work, when able-bodied young men work, it's good for them, for their dignity, their purpose, and it's good for the community," he added. "If you can't find a job, then volunteer in your community for 20 hours, and you will meet the requirement."
Defending the bill as a whole, Johnson said: "What Republicans are doing is an important and frankly heroic thing."
He alleged that Medicaid is being misused, saying, "It's intended for young, you know, single, pregnant women and the disabled and the elderly. But what's happening right now is you have a lot of people, for example, young men, able-bodied workers, who are on Medicaid. They're not working when they can."
Why It Matters: According to the Congressional Budget Office, the new provisions are projected to save $625 billion of the targeted $800 billion in savings over the next ten years. The controversial new measures have generated intense debate over the past few weeks.
In April, Trump said he would <a href="https://www.benzinga.com/government/25/04/45064937/donald-trump-threatens-to-veto-any-gop-bill-that-touches-medicaid-or-social-security-if-it-cuts-it-i-would-not-approve">"veto" any bill that includes cuts to Medicaid</a>. However, as the bill evolved, Medicaid cuts became central to its project of reducing federal spending, and <a href="https://www.benzinga.com/general/health-care/25/05/45345409/trumps-big-beautiful-bill-banks-on-huge-medicaid-cuts-as-its-cost-saving-centerpiece-see-who-risks-losing-coverage-under-the-gop-proposal">millions are set to lose coverage</a>.
Johnson previously denied that the bill would cut Medicaid, even as Trump&#8217;s crypto and AI advisor, David Sacks, acknowledged that the <a href="https://www.benzinga.com/25/05/45582778/trumps-big-beautiful-bill-passes-house-what-it-means-for-taxes-student-loans-medicaid-and-more" target="_blank" rel="noreferrer noopener"> bill</a> "cuts <a href="https://www.benzinga.com/general/health-care/25/05/45616625/trump-advisor-david-sacks-admits-new-bill-cuts-880-billion-from-medicaid-as-speaker-mike-johnson-insists-we-have-not-cut-medicaid-and-trump-says-working-class-wont-lose-health-insurance">$880 billion from Medicaid</a> over a decade.&#8221;
On the other hand, Sen.&nbsp;Josh Hawley&nbsp;(R-Mo.) wrote in an op-ed that the Republican party is facing an "identity crisis" and that Medicaid cuts are <a href="https://www.benzinga.com/25/05/45369487/josh-hawley-slams-gop-identity-crisis-over-medicaid-calls-proposed-cuts-morally-wrong-and-politically-suicidal">"morally wrong and politically suicidal."</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45714800/feds-christopher-waller-signals-caution-on-rate-cut-amid-tariff-driven-inflation-risks">Fed&#8217;s Christopher Waller Signals Caution On Rate Cut Amid Tariff-Driven Inflation Risks</a></li>
</ul>
Photo courtesy: Shutterstock

Politics

Speaker Mike Johnson Says 4.8 Million Won't Lose Medicaid 'Unless They Choose To Do So,' Calls GOP Cuts 'An Important And Frankly Heroic Thing'

Biotech

Financing

Offerings

Xilio Therapeutics Commenced An Underwritten Public Offering Of Pre-funded Warrants To Purchase Shares, Terms Not Disclosed

Taiwan Semiconductor Manufacturing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>)&nbsp;is weighing an <a target="_blank" href="https://www.benzinga.com/topic/tsmc" rel="noreferrer noopener">advanced gigafab in</a> the United Arab Emirates.
The contract chipmaker is exploring a complex of six factories (similar to its Arizona fab), subject to regulatory approval from the Trump administration, given the Gulf nation&#8217;s ties to China and Iran&#8217;s influence in the region.
Taiwan Semiconductor held meetings with&nbsp;Steve Witkoff, the U.S. special representative to the Middle East, and MGX officials, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-05-30/tsmc-is-said-to-evaluate-building-advanced-chip-plant-in-the-uae?sref=TBDibEcD" rel="noreferrer noopener">reported</a> on Friday, citing unnamed sources familiar with the matter.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/asia/25/05/45466444/to-serve-exploding-ai-chip-demand-taiwan-semiconductor-plans-9-advanced-factories" rel="noreferrer noopener">To Serve Exploding AI Chip Demand, Taiwan Semiconductor Plans 9 Advanced Factories</a>
Taiwan Semiconductor accounts for the majority share of advanced chips designed by the likes of&nbsp;Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)&nbsp;and&nbsp;Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) components that serve as the brains of electronic devices and are essential for training artificial-intelligence models.
Taiwan Semiconductor executives visited the UAE in 2024, aspiring for potential geographical diversification amid support from the Biden administration subject to stringent conditions. However, the talks failed to fructify.
After Trump assumed charge, the UAE sought a Taiwan Semiconductor fab and vied for easier access to Nvidia chips for AI data centers.
In March, the UAE announced a <a target="_blank" href="https://www.benzinga.com/25/05/45291509/nvidia-broadcom-amd-surge-as-trump-reshapes-ai-chip-export-rules-to-ease-market-pressure" rel="noreferrer noopener">$1.4 trillion commitment</a> to invest in the U.S.
Wedbush&nbsp;analyst Daniel Ives hailed Saudi Arabia as a <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45424189/nvidia-amazon-tesla-palantir-among-top-beneficiaries-of-1-trillion-saudi-arabia-ai-push-analyst-says" rel="noreferrer noopener">significant area of</a> penetration for the AI revolution after President Trump&#8217;s key trip to the Middle East. Ives noted that the market opportunity in Saudi Arabia could add another $1 trillion to the broader global AI market in the coming years, posing tailwind for Nvidia, Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>),&nbsp;Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>),&nbsp;Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
Price Action: TSM shares&nbsp;are trading lower by 0.94% to $191.50 premarket at&nbsp;last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/media/25/05/45653729/taiwan-semiconductor-and-intel-weigh-benefits-of-asmls-pricey-chipmaking-equipment" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor And Intel Weigh Benefits Of ASML&#8217;s Pricey Chipmaking Equipment</a></li>
</ul>
Image by Jack Hong via Shutterstock

Government

Tech

Media

AMZN

GOOG

GOOGL

MSFT

NVDA

PLTR

TSLA

Taiwan Semiconductor Eyes UAE Gigafab, Seeks Crucial US Green Light

Goldman Sachs analyst Jordan Alliger downgrades CSX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>) from Buy to Neutral and maintains the price target from $35 to $35.

Goldman Sachs Downgrades CSX to Neutral, Maintains Price Target to $35

DOLE

Dole Expands Public-Private Partnerships To Broaden Access To Social Services For Costa Rican Farm Workers

Global Net Lease, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNL#NYSE">GNL</a>) ("GNL" or the "Company") today announced the appointment of Robert Kauffman as Non-Executive Chairperson of its Board of Directors (the "Board"), effective immediately. Mr. Kauffman succeeds Sue Perrotty, who resigned from her position as Non-Executive Chairperson but will continue to serve on the Board as an independent director.
Mr. Kauffman, a Co-Founder and former member of the Board of Directors of Fortress Investment Group, joined the GNL Board in March 2024.

Management

Global Net Lease Appoints Robert Kauffman as New Chair After Sue Perrotty Steps Down From Role

USGO

US GoldMining To Join Russell 3000 Index Following Strong Progress At Whistler Gold-Copper Project

Press Releases

GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer

GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

GoodRx Reports Fourth Quarter and Full Year 2024 Results

GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending

GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement

GoodRx Introduces New E-commerce Experience for Retail Pharmacies

GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call

Comments

GoodRx Holdings

Notizie

Ultime notizie per GoodRx Holdings (NASDAQ:GDRX) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO